全球有源植入式医疗设备市场规模依设备类型、应用、最终用户、地区、预测：

主动式植入式医疗设备市场规模及预测

2024 年主动式植入式医疗设备市场规模为 235.5 亿美元，预计到 2032 年将达到 472.7 亿美元，2026 年至 2032 年的复合年增长率为 9.10%。

主动植入式医疗设备的市场驱动因素

主动植入式医疗设备市场的市场驱动因素可能受到多种因素的影响，其中包括：

慢性病的流行：随着全球人口老化和生活方式的改变，糖尿病、神经系统疾病和心血管疾病等慢性疾病正变得越来越普遍。植入式心臟復律去颤器 (AIMD) 在管理各种疾病方面发挥关键作用。例如，心律调节器、植入式心臟整流去颤器(ICD) 和神经刺激设备。

技术发展：持续的技术发展使得AIMD日益复杂且有效率。这些技术发展提升了AIMD的功能性和可靠性，包括小型化、更长的电池寿命、无线通讯和增强的感测能力。

微创手术日益受到偏好：微创手术技术因其恢復时间更快、併发症风险更低、患者预后改善等特点，越来越受到患者和医疗保健专业人员的欢迎。 AIMD 是这些手术不可或缺的一部分，因为它们专注于患处进行治疗。

医疗保健支出不断增长：由于医疗保健支出不断增长，尤其是在已开发国家，越来越多的人能够负担得起AIMD等新型医疗技术。政府计画和报销指南可能会进一步鼓励AIMD的使用，预计这将进一步推动市场扩张。

应用领域不断扩展：AIMD 的应用范围日益扩大，不仅限于神经内科和心臟病学等传统领域。这种扩展正在创造新的市场机会，包括泌尿系统、整形外科、疼痛管理，甚至肥胖管理等领域的应用。

老年人口不断增长：随着世界人口老化，需要频繁医疗干预的与老龄化相关的健康问题日益普遍。这导致对用于治疗肌肉骨骼疾病、老龄化性听力损失和尿失禁等疾病的AIMD的需求不断增加。

新兴市场：随着新兴国家可支配收入的提高和医疗基础设施的快速改善，AIMD 市场正在扩大。由于对尖端医疗设备和治疗的需求不断增长，这些地区拥有巨大的成长潜力。

患者对植入解决方案的偏好：相较于处方药和外部器械等传统治疗方法，患者通常更青睐植入式医疗设备。这种偏好源自于其长期成本效益、生活品质的提升以及便利性。

有源植入式医疗设备的市场限制

有多种因素可能对主动植入式医疗设备市场造成限制和挑战。这些因素包括：

监管障碍：製造商在遵守严格法规方面面临重大挑战。获得美国食品药物管理局(FDA) 和欧洲 CE 标誌等监管机构的核准可能耗时耗力且成本高昂。

昂贵：由于使用先进材料和技术，植入式医疗设备的生产成本高。这些成本转嫁给消费者，限制了其可用性和可负担性，尤其是在低度开发国家和医疗资源匮乏的地区。

併发症与风险：将电子设备插入体内有许多风险，包括感染疾病、设备故障和组织排斥反应。这些风险可能会阻碍患者和医护人员使用这些设备，尤其是在有替代疗法可用的情况下。

保险覆盖范围有限：有源植入式医疗设备的保险覆盖范围因器械类型、适应症和当地医疗保健法规而异。由于保险覆盖范围有限或报销困难，患者可能难以获得这些医疗设备，尤其是在选择性手术方面。

技术挑战：需要重大的技术进步来提高主动式植入式医疗设备的功能性、安全性和使用寿命。然而，电池寿命、小型化和无线通讯等技术障碍可能会阻碍创造力并限制这些设备的效用。

伦理与隐私问题：医疗设备与互联互通功能的整合引发了资料安全和病患隐私问题。对于製造商和医疗保健提供者而言，保护个人医疗资讯并遵守资料隐私法至关重要。

认知和采用有限：病患和医疗保健提供者可能尚未充分认识到有源嵌入型医疗设备的潜在益处。需要进行教育和推广工作，以提高人们对这些医疗设备的认知，并鼓励其在适当的护理环境中使用。

目录

第一章 引言

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章 市场概述

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章。主动式植入式医疗设备市场（依设备类型）

• 概述
• 植入式心臟整流去颤器（ICD）
• 心臟起搏器
• 神经刺激设备
• 植入式药物输注泵
• 植入式助听器
• 植入式心血管装置
• 其他的

第六章主动植入式医疗设备市场（依应用）

• 概述
• 心血管疾病
• 神经系统疾病
• 听力损失
• 糖尿病管理
• 整形外科
• 其他的

7. 主动植入式医疗设备市场（依最终用户）

• 概述
• 医院
• 门诊手术中心（ASC）
• 诊所和专科中心
• 居家医疗

8.植入式医疗设备市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第九章 竞争态势

• 概述
• 各公司市场排名
• 主要发展策略

第十章 公司简介

• Cochlear Ltd.
• Zimmer Biomet
• LivaNova PLC
• Abbott
• Straumann AG
• Medtronic
• Stryker
• 3M
• Dentsply Sirona
• Allergan Inc

第十一章 附录

• 相关调查

Active Implantable Medical Devices Market Size And Forecast

Active Implantable Medical Devices Market size was valued at USD 23.55 Billion in 2024 and is projected to reach USD 47.27 Billion by 2032, growing at a CAGR of 9.10% during the forecast period 2026-2032.

Global Active Implantable Medical Devices Market Drivers

The market drivers for the Active Implantable Medical Devices Market can be influenced by various factors. These may include:

Growing Prevalence of Chronic Diseases: Chronic diseases including diabetes, neurological problems, and cardiovascular diseases are growing increasingly common as the world's population ages and lifestyles alter. AIMDs play a critical role in the management of various disorders. Examples include pacemakers, implanted cardioverter defibrillators (ICDs), and neurostimulators.

Technological Developments: As a result of continuing technological developments, increasingly complex and efficient AIMDs have been created. These developments, which increase the functionality and dependability of these gadgets, include miniaturisation, longer-lasting batteries, wireless communication, and enhanced sensing capabilities.

Growing Preference for Minimally Invasive Surgery: Because of its shorter recovery periods, decreased risk of complications, and better patient outcomes, minimally invasive surgical methods are becoming more and more popular among patients and healthcare professionals. Because they provide focused therapy at the afflicted spot, AIMDs are essential to these procedures.

Growing Healthcare Expenditure: More people can now afford new medical technology, such as AIMDs, thanks to growing healthcare spending, especially in industrialised nations. Government programmes and reimbursement guidelines may further encourage the use of these devices, which would further propel market expansion.

Growing Application: AIMDs are being used in more and more medical fields outside of the more conventional ones, like neurology and cardiology. New market opportunities are being created by this expansion, which includes applications in urology, orthopaedics, pain treatment, and even obesity management.

Increasingly Ageing Population: Age-related health issues that frequently call for medical intervention are more common as the world's population ages. As a result, the need for AIMDs to treat ailments such musculoskeletal disorders, age-related hearing loss, and urine incontinence is rising.

Developing Markets: The market for AIMDs is growing as a result of emerging nations' growing disposable income and quickly improving healthcare infrastructure. Because there is a growing need for cutting-edge medical equipment and treatments, these areas have considerable potential for growth.

Implantable Solution Preference of Patients: Patients frequently favour implanted medical devices over more conventional forms of care like prescription drugs or external devices. This preference is frequently motivated by things like long-term cost-effectiveness, enhanced quality of life, and convenience.

Global Active Implantable Medical Devices Market Restraints

Several factors can act as restraints or challenges for the Active Implantable Medical Devices Market. These may include:

Regulatory Obstacles: Manufacturers face a great deal of difficulty in adhering to strict regulations. It can take a long time and money to get approvals from regulatory organisations like the FDA (Food and Drug Administration) in the US and the CE Mark in Europe.

Expensive: The production of active implantable medical devices can be costly due to the use of advanced materials and technologies. Customers bear the cost of these expenses, which restricts their accessibility and affordability, especially in underdeveloped nations or areas with tight healthcare resources.

Complications and dangers: Putting electrical devices into the body comes with a number of dangers, including the possibility of infection, device malfunction, and tissue rejection. Patients and healthcare professionals may be discouraged from using these devices due to concerns about these hazards, particularly if there are alternative therapies available.

Limited Coverage by Insurance: Depending on the type of device, the medical indication, and local healthcare regulations, insurance coverage for active implantable medical devices varies. Patients may find it difficult to obtain these devices due to limited coverage or difficulties with reimbursement, especially for elective treatments.

Technological Difficulties: Increasing the functionality, safety, and longevity of active implanted medical devices requires significant technological advancements. Nonetheless, technical obstacles like battery life, compact size, and wireless communication might hinder creativity and restrict the usefulness of these gadgets.

Ethical and Privacy Issues: Data security and patient privacy are issues that are brought up by the integration of medical equipment with connectivity characteristics. For manufacturers and healthcare providers, protecting private health information and making sure data privacy laws are followed are essential.

Limited Awareness and Adoption: Patients and healthcare providers may not be fully aware of the potential advantages of active implanted medical devices. To raise awareness of these devices and encourage their use in suitable therapeutic settings, education and outreach initiatives are required.

Global Active Implantable Medical Devices Market Segmentation Analysis

The Global Active Implantable Medical Devices Market is Segmented on the basis of Type of Device, Application, End-User, and Geography.

Active Implantable Medical Devices Market Segmentation Analysis

Active Implantable Medical Devices Market, By Type of Device

• Implantable Cardioverter Defibrillators (ICDs): Devices designed to monitor heart rhythm and deliver electrical shocks to restore normal heart rhythm in patients at risk of sudden cardiac arrest.
• Cardiac Pacemakers: Implantable devices that deliver electrical impulses to regulate heart rate and rhythm in patients with bradycardia or other heart rhythm disorders.
• Neurostimulators: Implantable devices that deliver electrical stimulation to specific nerves or areas of the brain to manage chronic pain, movement disorders (e.g., Parkinson's disease), epilepsy, and other neurological conditions.
• Implantable Drug Infusion Pumps: Devices that deliver medications directly into the body, typically used to manage chronic pain, spasticity, and other conditions requiring continuous drug delivery.
• Implantable Hearing Devices: Devices such as cochlear implants and bone-anchored hearing aids (BAHA) that restore hearing function in individuals with severe hearing loss or deafness.
• Implantable Cardiovascular Devices: Including implantable heart monitors, left ventricular assist devices (LVADs), and other devices used to monitor and support cardiovascular function in patients with heart failure and other cardiac conditions.
• Other Implantable Devices: Such as implantable glucose monitors for diabetes management, implantable drug-eluting stents for coronary artery disease, and implantable orthopedic devices for bone repair and joint replacement.

Active Implantable Medical Devices Market, By Application

• Cardiovascular Diseases: Devices used for the management of various cardiovascular conditions including arrhythmias, heart failure, and coronary artery disease.
• Neurological Disorders: Devices used to manage chronic pain, movement disorders, epilepsy, and other neurological conditions.
• Hearing Loss: Devices used to restore hearing function in individuals with severe hearing loss or deafness.
• Diabetes Management: Implantable glucose monitors and insulin pumps used for continuous glucose monitoring and insulin delivery in diabetic patients.
• Orthopedics: Implantable orthopedic devices for bone repair, joint replacement, and spinal stabilization.
• Others: Including implantable devices for urological disorders, gastrointestinal disorders, and other medical conditions.

Active Implantable Medical Devices Market, By End-User

• Hospitals: Including both general hospitals and specialized cardiac centers, neurological centers, and orthopedic centers where implantable medical devices are implanted and managed.
• Ambulatory Surgical Centers (ASCs): Facilities that perform outpatient procedures, including implantation of certain types of implantable medical devices.
• Clinics and Specialty Centers: Including cardiology clinics, neurology clinics, diabetes clinics, and other specialized healthcare facilities that provide diagnostic and therapeutic services related to implantable devices.
• Home Care Settings: Some implantable medical devices, such as insulin pumps and home monitoring devices, may be managed by patients themselves or by caregivers in home care settings.

Active Implantable Medical Devices Market, By Region

• North America: A major market for active implantable medical devices, driven by advanced healthcare infrastructure, high healthcare expenditure, and technological innovation.
• Europe: Europe has a significant market for active implantable medical devices, with a strong focus on cardiovascular and neurological applications.
• Asia-Pacific: Emerging market with growing demand for implantable medical devices, driven by increasing prevalence of chronic diseases and improving healthcare infrastructure.
• Latin America, Middle East, and Africa: Growing markets with expanding access to healthcare services and increasing adoption of advanced medical technologies.

Key Players

The "Global Active Implantable Medical Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Cochlear Ltd., Zimmer Biomet, LivaNova PLC, Abbott, Straumann AG, Medtronic, Stryker, 3M, Dentsply Sirona, Allergan Inc., Boston Scientific Corporation, BIOTRONIK SE & Co. KG, MED-EL, Sonova Holding AG, William Demant Holding A/S, and Nurotron Biotechnology Co., Ltd.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY TYPE OF DEVICE

• 5.1 Overview
• 5.2 Implantable Cardioverter Defibrillators (ICDs)
• 5.3 Cardiac Pacemakers
• 5.4 Neurostimulators
• 5.5 Implantable Drug Infusion Pumps
• 5.6 Implantable Hearing Devices
• 5.7 Implantable Cardiovascular Devices
• 5.8 Other Implantable Devices

6 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Cardiovascular Diseases
• 6.3 Neurological Disorders
• 6.4 Hearing Loss
• 6.5 Diabetes Management
• 6.6 Orthopedics
• 6.7 Others

7 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ambulatory Surgical Centers (ASCs)
• 7.4 Clinics and Specialty Centers
• 7.5 Home Care Settings

8 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Cochlear Ltd.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Zimmer Biomet
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 LivaNova PLC
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Abbott
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Straumann AG
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Medtronic
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Stryker
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 3M
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Dentsply Sirona
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Allergan Inc
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Research